You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Pediatric Medulloblastoma – Update on Molecular Classification Driving Targeted Therapies
|
|---|---|
| Published in |
Frontiers in oncology, July 2014
|
| DOI | 10.3389/fonc.2014.00176 |
| Pubmed ID | |
| Authors |
Ruth-Mary DeSouza, Benjamin R. T. Jones, Stephen P. Lowis, Kathreena M. Kurian |
| Abstract |
As advances in the molecular and genetic profiling of pediatric medulloblastoma evolve, associations with prognosis and treatment are found (prognostic and predictive biomarkers) and research is directed at molecular therapies. Medulloblastoma typically affects young patients, where the implications of any treatment on the developing brain must be carefully considered. The aim of this article is to provide a clear comprehensible update on the role molecular profiling and subgroups in pediatric medulloblastoma as it is likely to contribute significantly toward prognostication. Knowledge of this classification is of particular interest because there are new molecular therapies targeting the Shh subgroup of medulloblastomas. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 227 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| Czechia | 1 | <1% |
| France | 1 | <1% |
| Unknown | 224 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 41 | 18% |
| Student > Ph. D. Student | 29 | 13% |
| Other | 28 | 12% |
| Student > Master | 28 | 12% |
| Researcher | 24 | 11% |
| Other | 41 | 18% |
| Unknown | 36 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 70 | 31% |
| Biochemistry, Genetics and Molecular Biology | 43 | 19% |
| Agricultural and Biological Sciences | 35 | 15% |
| Neuroscience | 16 | 7% |
| Nursing and Health Professions | 3 | 1% |
| Other | 19 | 8% |
| Unknown | 41 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 August 2023.
All research outputs
#8,262,107
of 25,374,647 outputs
Outputs from Frontiers in oncology
#3,072
of 22,416 outputs
Outputs of similar age
#75,300
of 239,414 outputs
Outputs of similar age from Frontiers in oncology
#20
of 94 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 22,416 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 239,414 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 94 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.